Table 1.
Imm[b] | IgG total MUC1 Imm 3 | IgG total MUC1 EP | IgG1 MUC1 EP | IgG2a MUC1 EP | IgG2b MUC1 EP | IgG3 MUC1 EP | IgM MUC1 EP | IgG total Thelper EP |
---|---|---|---|---|---|---|---|---|
1 | 28 500 | 59 100 | 17 800 | 7000 | 26 800 | 11 300 | 100 | 300 |
2 | 700 | 1000 | 400 | 0 | 600 | 200 | 50 | 1000 |
3 | 7800 | 10 600 | 9000 | 1000 | 6800 | 5300 | 50 | 50 |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 50 |
IFA | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 50 |
Anti-MUC1 and anti-Thelper antibody titers are presented as median values for groups of mice. ELISA plates were coated with BSA-MI-CTSAPDT-(αGalNAc)RPAP conjugate for anti-MUC1 antibody titers or NeutrAvidin-biotin-Thelper for anti-Thelper antibody titers. Titers were determined by linear regression analysis, with plotting of dilution versus absorbance. Titers are defined as the highest dilutions yielding optical densities of 0.1 or greater relative to normal control mouse sera. [b] For immunizations with 1 and 2 liposomal preparations were employed, whereas 3 and 4 were given together with IFA. MT.MUC1 tumors were induced between the third and the fourth immunization. EP indicates endpoint serum samples.